Son[VEER]
Upgrade · Coming SoonAUROPHARMA
NSE: AUROPHARMA
₹1,679.80
Healthcare · Nifty 500 · as of 11SEP2026
Long-Term Read
↑ Strongly Veering Up · 0.84
Score
84/100
This is a percentile rank of this stock against the rest of the Nifty 500 today, not a probability or return forecast.
Long-Term Drivers
TechLong-Term Momentum
200-session price momentum.
0.3909
as of 11SEP2026
+30 pts to score
TechSector Tailwind
Sector relative strength vs. the broader market.
0.0003
as of 11SEP2026
0 pts to score
What changed, and when
05AUG2026
↑ Flipped to Strongly Veering Up
Driven by: Sector Momentum (Extended), Sector Tailwind
04AUG2026
↑ Flipped to Veering Up
Driven by: Sector Tailwind, Long-Term Momentum
27JUL2026
↑ Flipped to Strongly Veering Up
Driven by: Sector Momentum (Extended), Long-Term Momentum
17JUL2026
↑ Veering Up · first read on record
Sector Peers · Healthcare
Past Prints
Track record begins at launch. Check back soon.